A panelist discusses how their institution evaluates biosimilars for formulary inclusion through a systematic review process ...
In a new study, researchers found that time-in-range for healthy blood sugar could be a viable marker of glycemic control and potentially could be used to predict complications of type 1 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback